After reporting that their COVID-19 vaccine candidate had achieved over 95% effectiveness, Pfizer is now seeking emergency use authorization from the Food and Drug Administration.
The company is looking to start rolling out limited shot dosages across the country. Pfizer has also submitted applications in Europe and the United Kingdom.
It is believed that protection plus a great safety record will allow the vaccine to obtain emergency use.
“Our work to deliver a safe and effective vaccine has never been more urgent,” Pfizer CEO Albert Bourla said in a statement.